Policy Update: Could the EU Move Toward Pre-Market Authorisation for Novel Nicotine Products?

The European Union is reassessing whether its tobacco and nicotine framework remains fit for a market that has changed significantly since the Tobacco Products Directive (TPD) was adopted. Nicotine pouches, e-cigarettes, heated tobacco products and other novel products have expanded rapidly, creating regulatory questions that the existing framework does not address consistently. One possibility receiving…

How Much Nicotine Is Enough? Why Effective Smoking Substitution Requires More Than Counting Cigarettes

When adults attempt to stop smoking using nicotine replacement therapy, e-cigarettes or other non-combustible nicotine products, one practical question quickly emerges: how much nicotine is enough? The answer matters because cigarette dependence varies considerably between smokers. Two people who smoke the same number of cigarettes each day may not absorb the same amount of nicotine…

India’s Nicotine Pouch Debate Shows Why Regulatory Classification Matters

The debate over nicotine pouches in India is increasingly becoming a debate about regulatory classification. Tobacco-free nicotine pouches do not fit comfortably within some of the legal categories created for cigarettes, smokeless tobacco, electronic cigarettes or medicinal nicotine products. Recent commentary has therefore focused on whether existing Indian laws adequately cover them and which authorities…

Beyond the Evidence: Why the Nicotine Sector Needs Credibility, Collaboration and Long-Term Thinking

The scientific evidence surrounding smoke-free nicotine products is only one part of the challenge facing the nicotine sector. Even where manufacturers believe the evidence supports differentiated approaches to regulation, that evidence does not automatically translate into public understanding, regulatory acceptance or proportionate policy. That disconnect was at the centre of the GINN panel “We’re Right…

We’re Right but We’re Losing – How the Nicotine Sector Wastes Its Own Advantage

GINN Panel | InterTabac Dortmund 2026 Moderator: Joel Rubenstein, GINN Panelists: Tomasz Płaska, Chemnovatic; Jack Li, HG Innovation; Shivam Bihani, Satyam’s Sun Products (MYNT) The following transcript has been lightly edited for clarity and readability while preserving the substance and meaning of the speakers’ remarks.   Introductions Joel Rubenstein: Hello, everybody. We’re going to shift…

Evidence Is Not Enough: Why the Nicotine Sector Must Strengthen Its Case

Reporting contributed by Kiran Sidhu   “For those in the pouch industry, the harm reduction benefit of choosing a non-combustible nicotine product is irrefutably evident,” Joel Rubenstein told the audience. However, he said, step outside and the environment is hostile to this evidence-based fact.    Rubenstein, an independent commercial consultant, was speaking at InterTabac, an…

GINN Response: Nicotine Pouches Are Not “Beyond the Law” in India

A recent explainer asks whether nicotine pouches are “beyond the law” in India and concludes by suggesting that the government could quickly prohibit their import and sale on health grounds. The article identifies genuine uncertainty around the treatment of tobacco-free nicotine pouches under India’s existing legislation. However, the suggestion that these products effectively occupy a…